{"name":"THPharm Corp.","slug":"thpharm-corp","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"THP-00101","genericName":"THP-00101","slug":"thp-00101","indication":"Type 2 diabetes","status":"phase_3"},{"name":"THP-00103","genericName":"THP-00103","slug":"thp-00103","indication":"Type 2 diabetes","status":"phase_3"},{"name":"THP-00105","genericName":"THP-00105","slug":"thp-00105","indication":"Type 2 diabetes","status":"phase_3"},{"name":"THP-00106","genericName":"THP-00106","slug":"thp-00106","indication":"Type 2 diabetes","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"THP-00102","genericName":"THP-00102","slug":"thp-00102","indication":"Condition 1","status":"phase_3"},{"name":"THP-00104","genericName":"THP-00104","slug":"thp-00104","indication":"Condition 1","status":"phase_3"}]}],"pipeline":[{"name":"THP-00101","genericName":"THP-00101","slug":"thp-00101","phase":"phase_3","mechanism":"THP-00101 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"THP-00102","genericName":"THP-00102","slug":"thp-00102","phase":"phase_3","mechanism":"THP-00102 is a small molecule that targets the molecular target.","indications":["Condition 1"],"catalyst":""},{"name":"THP-00103","genericName":"THP-00103","slug":"thp-00103","phase":"phase_3","mechanism":"THP-00103 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"THP-00104","genericName":"THP-00104","slug":"thp-00104","phase":"phase_3","mechanism":"THP-00104 is a small molecule that targets the molecular target.","indications":["Condition 1"],"catalyst":""},{"name":"THP-00105","genericName":"THP-00105","slug":"thp-00105","phase":"phase_3","mechanism":"THP-00105 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"THP-00106","genericName":"THP-00106","slug":"thp-00106","phase":"phase_3","mechanism":"THP-00106 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":6,"phaseCounts":{"phase_3":6},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}